Actively Recruiting
Radiological Prediction of Response to Neoadjuvant Chemoimmunotherapy for Triple-negative Breast Cancer
Led by Centre Henri Becquerel · Updated on 2026-01-02
115
Participants Needed
1
Research Sites
235 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of our study is to find the best imaging technique, alone or in combination, that can best predict a complete response (absence of tumour cells). It also seems important to identify blood markers able to predict which patients will benefit most from treatment, with a view to personalising them, or which patients will be most at risk of toxicities, particularly related to immunotherapy, with a view to personalising monitoring.
CONDITIONS
Official Title
Radiological Prediction of Response to Neoadjuvant Chemoimmunotherapy for Triple-negative Breast Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed informed consent
- Histologically confirmed triple-negative breast cancer
- Planned to receive neoadjuvant chemo-immunotherapy
- Age between 18 and 75 years
- Affiliated with or beneficiary of a social protection scheme
You will not qualify if you...
- Pregnant or breastfeeding women
- Contraindication to immunotherapy
- Inflammatory breast cancer (T4d)
- Metastatic disease
- Allergies to iodine or gadolinium
- Presence of breast augmentation prosthesis (for angiography/mammography)
- Claustrophobia
- Renal contraindication to contrast agents
- Presence of ferromagnetic material
- Uncontrolled diabetes (blood glucose >10 mmol/L)
- Inability to understand or comply with study requirements
- Under guardianship, curatorship, or judicial protection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre Henri Becquerel
Rouen, France, 76038
Actively Recruiting
Research Team
F
Florian Clatot, MD, PhD
CONTACT
D
Doriane Richard, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here